About
Technology
Issues
FAQ
Links
Official Page
A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.